Skip to main content
OpenTrials

Clinical trial condition

Huntington Disease

Explore clinical trials studying Huntington Disease. Study availability and eligibility vary by location and protocol.

141 public trials 32 recruiting studies
Refine in advanced search Browse all conditions

Huntington Disease trial results

Active, Not Recruiting

GENERATION HD2. A Study to Evaluate the Safety, Biomarkers, and Efficacy of Tominersen Compared With Placebo in Participants With Prodromal and Early Manifest Huntington's Disease

NCT05686551

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +13 more
Locations
  • Uab Medicine Birmingham, Alabama, United States
  • Barrow Neurological Institute Phoenix, Arizona, United States
  • University of California Davis Medical System Sacramento, California, United States
  • CenExel Rocky Mountain Clinical Research, LLC Englewood, Colorado, United States
View all 70 locations
View Trial Details
Active, Not Recruiting

Study of SKY-0515 for Safety, Efficacy, and Pharmacodynamics in Participants With Huntington's Disease

NCT06873334

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +17 more
Locations
  • John Hunter Hospital New Lambton Heights, New South Wales, Australia
  • Westmead Hospital Westmead, New South Wales, Australia
  • The University of Queensland Herston, Queensland, Australia
  • Flinders Medical Centre Adelaide, South Australia, Australia
View Trial Details
Active, Not Recruiting

A Phase I Clinical Study of ER2001 Injection for the Treatment of Early Manifest Huntington's Disease.

NCT07339514

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +13 more
Locations
  • First Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China
  • First Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China
  • West China Hospital of Sichuan University Chengdu, Sichuan, China
View Trial Details
Active, Not Recruiting

An Extension Study to Evaluate the Long-Term Safety and Efficacy of Votoplam in Participants With Huntington's Disease (HD)

NCT06254482

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +17 more
Locations
  • Novartis Investigative Site Clayton, Australia
  • Novartis Investigative Site Westmead, Australia
  • Novartis Investigative Site Innsbruck, Austria
  • Novartis Investigative Site Ottawa, Canada
View all 24 locations
View Trial Details

Related conditions